Acceptability of Reminder Letters for Papanicolaou Tests: A Survey ofWomen from 23 Family Health Networks in Ontario

Journal of Obstetrics and Gynaecology Canada

Volumn 29, Issue 10, 2007, Pages 829-834

  Karwalajtys, Tina ^a   Kaczorowski, Janusz ^a,b   Lohfeld, Lynne ^a   Laryea, Stephanie ^a   Anderson, Kelly ^a   Roder, Stefanie ^a   Sebaldt, Rolf J ^a  

^a MCMASTER UNIVERSITY   (Canada)

^b UNIVERSITY OF BRITISH COLUMBIA   (Canada)

Author keywords

Family practice; Focus groups; Papanicolaou test; Preventive health services; Questionnaires; Reminder systems

Indexed keywords

ADULT; AGED; ARTICLE; AWARENESS; CANADA; CONTROLLED STUDY; EDUCATION; EMPLOYMENT; FAMILY HEALTH; FEMALE; GENERAL PRACTITIONER; HEALTH CARE DELIVERY; HEALTH CARE PRACTICE; HEALTH SURVEY; HUMAN; LOGISTIC REGRESSION ANALYSIS; MAJOR CLINICAL STUDY; MEDICAL INFORMATION; PAPANICOLAOU TEST; POPULATION RESEARCH; PREVENTIVE MEDICINE; PRIMARY MEDICAL CARE; QUESTIONNAIRE; SCREENING TEST; WOMEN'S HEALTH; EPIDEMIOLOGY; HEALTH PROMOTION; METHODOLOGY; MIDDLE AGED; PATIENT COMPLIANCE; REMINDER SYSTEM; VAGINA SMEAR;

ADULT; AGED; FEMALE; HEALTH CARE SURVEYS; HEALTH PROMOTION; HUMANS; MIDDLE AGED; ONTARIO; PATIENT COMPLIANCE; REMINDER SYSTEMS; VAGINAL SMEARS; WOMEN'S HEALTH;

EID: 38449087777     PISSN: 17012163     EISSN: None     Source Type: Journal    
DOI: 10.1016/S1701-2163(16)32640-8     Document Type: Article

References (33)

1. Crawford A.G., Sikirica V., Goldfarb N., Popiel R.G., Patel M., Wang C., et al. Interactive voice response reminder effects on preventive service utilization. Am J Med Qual 2005, 20:329-336.
2. Ornstein S.M., Garr D.R., Jenkins R.G., Rust P.F., Arnon A. Computer-generated physician and patient reminders tools to improve population adherence to selected preventive services. J Fam Pract 1991, 32:82-90.
3. Johnston G.M., Boyd C.J., MacIsaac M.A., Rhodes J.W., Grimshaw R.N. Effectiveness of letters to Cape Breton women who have not had a recent Pap smear. Chronic Dis Can 2003, 24:49-56.
4. Tseng D.S., Cox E., Plane M.B., Hla K.M. Efficacy of patient letter reminders on cervical cancer screening: a meta-analysis. J Gen Intern Med 2001, 16:563-568.
5. Lantz P.M., Stencil D., Lippert M.T., Beversdork S., Jaros L., Remington P.L. Breast and cervical cancer screening in a low-income managed care sample: the efficacy of physician letters and phone calls. Am J Public Health 1995, 85(6):834-836.
6. Somkin C.P., Hiatt R.A., Hurley L.B., Gruskin E., Ackerson L., Larson P. The effect of patient and provider reminders on mammography and Papanicolaou smear screening in a large health maintenance organization. Arch Intern Med 1997, 157:1658-1664.
7. McLachlin CM, Mai V, Murphy J, Fung Kee Fung M, Chambers A, and members of the Cervical Screening Guidelines Development Committee of the Ontario Cervical Screening Program and the Gynecology Cancer Disease Site Group of Cancer Care Ontario. Cervical screening: a systematic review. Evidence-based series: Section 2; Program in Evidence-based Care (PEBC), Cancer Care Ontario (CCO). Available at: . Accessed April 23, 2007. http://www.cancercare.on.ca/pdf/pebc_cervical_screen.pdf.
8. Parkin D.M., Muir C.S., Whelan S.L., Gao Y.T., Ferlay J., Powell J. eds. Cancer Incidence in Five Continents. Vol 6. Lyon: IARC Sci Publications 1992, 120:35-870.
9. Hunter R.D. Carcinoma of the cervix. Oxford Textbook of Oncology 1995, Vol 2:1324-1349. Oxford University Press, Oxford.
10. Public Health Agency of Canada. Cervical cancer in Canada. Available at: . Accessed March 7, 2007. http://www.phac-aspc.gc.ca/publicat/updates/cervix-98_e.html.
11. Liu S., Semenciw R., Probert A., Mao Y. Cervical cancer in Canada: changing patterns in incidence and mortality. Int J Gynecol Cancer 2001, 11(1):24-31.
12. Pichichero M.E. Who should get the HPV vaccine?. J Fam Pract 2007, 56(3):197-202.
13. Meijer CJ, Van Kemenade FJ, Bais AG, Berkhof H, Verheijen RHM, Snijders PJF, et al. HPV testing on self-sampled vaginal specimens: an effective alternative for non-responders of cervical screening. PS25-4: 23rd International Papillomavirus Conference and Clinical Workshop. Prague, Czech Republic; September 1-7, 2006.
14. Canadian Task Force on Preventive Health Care. Available at: . Accessed March 7, 2007. http://www.ctfphc.org.
15. Sigurdsson K. Effect of organized screening on the risk of cervical cancer. evaluation of screening activity in Iceland, 1964-1991. Int J Cancer 1993, 54:563-570.
16. Laara E., Day N.E., Hakama M. Trends in mortality from cervical cancer in the Nordic countries: association with organised screening programmes. Lancet 1987, 1:1247-1249.
17. Statistics Canada Canadian community health survey, Cycle 1.1, 2000-2001 2002, Statistics Canada, Ottawa.
18. Lemelin J., Hogg W., Baskerville N. Evidence to action: a tailored multifaceted approach to changing family physician practice patterns and improving preventive care. CMAJ 2001, 164(6):757-763.
19. Marcus A.C., Crane L.A. A review of cervical cancer screening intervention research: implications for public health programs and future research. Prev Med 1998, 27(1):13-31.
20. Dignan M.B., Michielutte R., Jones-Lighty D.D., Bahnson J. Factors influencing the return rate in a direct mail campaign to inform minority women about prevention of cervical cancer. Public Health Rep 1994, 109(4):507-511.
21. Byles J.E., Redman S., Sanson-Fisher R.W., Boyle C. A trial of two direct-mail strategies to encourage women to have Pap smears. Health Promot Int 1995, 10:5-16.
22. Forbes C., Jepson R., Martin-Hirsch P. Interventions targeted at women to encourage the uptake of cervical screening. Cochrane Database Syst Rev 2002, 3.
23. Bowman J., Sanson-Fisher R., Boyle C., Pope S., Redman S. A randomized controlled trial of strategies to prompt attendance for a Pap smear. J Med Screen 1995, 2(4):211-218.
24. Segnan N., Senore C., Giordano L., Ponti A., Ronco G. Promoting participation in a population screening program for breast and cervical cancer: a randomized controlled trial. Tumori 1998, 84(3):348-353.
25. Anderson K.K., Sebaldt R.J., Lohfeld L., Burgess K., Donald F.C., Kaczorowski J. Views of family physicians in southwestern Ontario on preventive care services and performance incentives. Fam Pract 2006, 23:469-471.
26. Yabroff K.R., Mangan P., Mandelblatt J. Effectiveness of interventions to increase Papanicolaou smear use. J Am Board Fam Pract 2003, 16:188-203.
27. Lerman C., Rimer B., Trock B., Balshem A., Engstrom P.F. Factors associated with repeat adherence to breast cancer screening. Prev Med 1990, 19:279-290.
28. Zapka J.G., Costanza M.E., Stoddard A., Green H.L. Breast cancer screening: perceptions and experience of primary care physicians, radiologists and women. Prog Clin Biol Res 1990, 339:253-257.
29. O'Connor A.M., Perrault D.J. Importance of physician's role highlighted in survey of women's breast screening practices. Can J Public Health 1994, 86:42-45.
30. Dillman D. Mail and Internet Surveys: the tailored design method 2000, John Wiley & Sons, New York.
31. Addison R.B. A grounded hermeneutic editing approach. Doing qualitative research 1999, 145-161. Sage Publications, Thousand Oaks, CA. 2nd ed. B.F. Crabtree, W.L. Miller (Eds.).
32. Reeves M.J., Remington P.L. Use of patient reminder letters to promote cancer screening services in women: a population-based study in Wisconsin. Prev Med 1999, 29:202-209.
33. Jepson R.G., Hewison J., Thompson A.G.H., Weller D. How should we measure informed choice? The case of cancer screening. J Med Ethics 2005, 31:192-196.